Arrowhead Pharmaceuticals (ARWR) Net Cash Flow Growth (5y) (2015 - 2026)
Arrowhead Pharmaceuticals (ARWR) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn |
| 10 | Arrowhead Pharmaceuticals | 12.35 Bn | 10.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.56% |
| Dec 31, 2025 | -46.85% |
| Sep 30, 2025 | 26.75% |
| Jun 30, 2025 | -8.45% |
| Mar 31, 2025 | 21.49% |
| Dec 31, 2024 | -17.12% |
| Jun 30, 2024 | -18.78% |
| Mar 31, 2024 | -11.98% |
| Dec 31, 2023 | -18.44% |
| Jun 30, 2023 | 6.71% |
| Mar 31, 2023 | -25.82% |
| Dec 31, 2022 | 55.50% |
| Sep 30, 2022 | -18.34% |
| Jun 30, 2022 | 33.71% |
| Mar 31, 2022 | 33.68% |
| Dec 31, 2021 | -49.80% |
| Sep 30, 2021 | -40.05% |
| Jun 30, 2021 | -47.33% |
| Mar 31, 2021 | 84.87% |
| Dec 31, 2020 | 28.09% |